Chronic migraine is a debilitating condition affecting millions worldwide. Conventional treatments often provide only partial relief, leaving many sufferers seeking alternative therapies. Stem cell therapy has emerged as a promising solution for chronic migraine management, offering the potential for long-term pain reduction and improved quality of

growth. Moreover, microvesicles (MVs) isolated from MSCs caused major decreases in tumor cell proliferation by way of inhibiting cell cycle progression and inducing apoptosis and necrosis on the tumor cells. These observations had been verified by in vivo Marcio Malogolowkin, Main of pediatric hematology-oncology at UC Davis overall health, said H